CAS 1021868-76-7

(+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM

CAS: 1021868-76-7

Fórmula: C₂₂H₃₁Cl₂N₂NaO₄

Pureza: 99.71%

Cor e Forma: Solid

Peso molecular: 481.3883

Ref: IN-DA008S4V

Lorglumide sodium salt

CAS: 1021868-76-7

Lorglumide sodium salt

Pureza: ≥98%

Peso molecular: 481.39g/mol

Ref: 54-BUP21410

Lorglumide sodium salt

CAS: 1021868-76-7

Fórmula: C₂₂H₃₁Cl₂N₂NaO₄

Peso molecular: 481.39

Ref: 7W-GP2997

Lorglumide sodium salt

CAS: 1021868-76-7

Lorglumide sodium salt is a guanine nucleotide-binding protein that has low potency and is used as an experimental model for polymerase chain reaction. It interacts with the transcriptional regulator cck-a, which inhibits the production of estradiol benzoate, cortisol concentration, and energy metabolism. Lorglumide sodium salt also interacts with receptors to inhibit the activity of peptide hormones and carcinoma cell lines.

Fórmula: C₂₂H₃₁Cl₂N₂NaO₄

Pureza: Min. 95%

Cor e Forma: Powder

Peso molecular: 481.39 g/mol

Ref: 3D-FL43268

Lorglumide Sodium Salt

Produto Controlado

CAS: 1021868-76-7

Stability Hygroscopic
Applications Lorglumide Sodium Salt is a nonpeptidic antagonist of the CCK A recepotor, and minimally effective at the CCK B receptor. It blocks CCK -mediated muscle contraction, pancreatic growth and secretion.
References Makovec, F. et al.: J. Med. Chem., 35, 28 (1992);

Fórmula: C₂₂H₃₁Cl₂N₂NaO₄

Cor e Forma: Neat

Peso molecular: 481.39

Ref: TR-L469910

Lorglumide sodium salt

CAS: 1021868-76-7

Lorglumide sodium salt (CR-1409 sodium salt) is an antagonist of cholecystokinin receptors (CCK).

Fórmula: C₂₂H₃₁Cl₂N₂NaO₄

Pureza: 99.32%

Cor e Forma: Solid

Peso molecular: 481.39

Ref: TM-T11868